266 related articles for article (PubMed ID: 26534742)
1. Serum eosinophil-derived neurotoxin: correlation with persistent airflow limitation in adults with house-dust mite allergic asthma.
Gon Y; Ito R; Hattori T; Hiranuma H; Kumasawa F; Kozu Y; Endo D; Koyama D; Shintani Y; Eriko T; Soda K; Maruoka S; Hashimoto S
Allergy Asthma Proc; 2015; 36(6):e113-20. PubMed ID: 26534742
[TBL] [Abstract][Full Text] [Related]
2. Eosinophil-derived neurotoxin in childhood asthma: correlation with disease severity.
Kim CK; Callaway Z; Fletcher R; Koh YY
J Asthma; 2010 Jun; 47(5):568-73. PubMed ID: 20560830
[TBL] [Abstract][Full Text] [Related]
3. Correlation of eosinophil derived neurotoxin with airway resistance in asthmatics.
Badar A; Hussain MM; Saeed W; Aslam M
J Pak Med Assoc; 2010 Feb; 60(2):97-101. PubMed ID: 20209693
[TBL] [Abstract][Full Text] [Related]
4. Serum eosinophil-derived neurotoxin (EDN) in diagnosis and evaluation of severity and bronchial hyperresponsiveness in childhood asthma.
Kim KW; Lee KE; Kim ES; Song TW; Sohn MH; Kim KE
Lung; 2007; 185(2):97-103. PubMed ID: 17393238
[TBL] [Abstract][Full Text] [Related]
5. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma.
Yüksel B; Aydemir C; Ustündag G; Eldeş N; Kutsal E; Can M; Demirtaş S; Tomaç N
Turk J Pediatr; 2009; 51(5):460-5. PubMed ID: 20112601
[TBL] [Abstract][Full Text] [Related]
6. RANTES in exhaled breath condensate of patients with severe persistent allergic asthma during omalizumab therapy.
Zietkowski Z; Skiepko R; Tomasiak-Lozowska MM; Lenczewska D; Bodzenta-Lukaszyk A
Int Arch Allergy Immunol; 2011; 154(1):25-32. PubMed ID: 20664274
[TBL] [Abstract][Full Text] [Related]
7. Reductions in eosinophil biomarkers by benralizumab in patients with asthma.
Pham TH; Damera G; Newbold P; Ranade K
Respir Med; 2016 Feb; 111():21-9. PubMed ID: 26775606
[TBL] [Abstract][Full Text] [Related]
8. Utility of serum eosinophil-derived neurotoxin (EDN) measurement by ELISA in young children with asthma.
Kim CK; Callaway Z; Park JS; Kwon E
Allergol Int; 2017 Jan; 66(1):70-74. PubMed ID: 27329145
[TBL] [Abstract][Full Text] [Related]
9. Eosinophil-derived neurotoxin as a biomarker for disease severity and relapse in recalcitrant atopic dermatitis.
Kim HS; Kim JH; Seo YM; Chun YH; Yoon JS; Kim HH; Lee JS; Kim JT
Ann Allergy Asthma Immunol; 2017 Nov; 119(5):441-445. PubMed ID: 28866306
[TBL] [Abstract][Full Text] [Related]
10. Eosinophils and eosinophil-derived proteins in children with moderate asthma.
Hoekstra MO; Hovenga H; Gerritsen J; Kauffman HF
Eur Respir J; 1996 Nov; 9(11):2231-5. PubMed ID: 8947065
[TBL] [Abstract][Full Text] [Related]
11. Blood eosinophil cationic protein and eosinophil-derived neurotoxin are associated with different asthma expression and evolution in adults.
Granger V; Zerimech F; Arab J; Siroux V; de Nadai P; Tsicopoulos A; Matran R; Akiki Z; Nadif R
Thorax; 2022 Jun; 77(6):552-562. PubMed ID: 34615736
[TBL] [Abstract][Full Text] [Related]
12. [Correlation of serum eosinophil cationic protein with the severity of allergic rhinitis in childhood].
Zhu XJ; Lu MP; Chen RX; Zhu LP; Qi QH; Yin M; Cheng L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 47(8):628-32. PubMed ID: 23141391
[TBL] [Abstract][Full Text] [Related]
13. Total and allergen-specific IgE levels in serum reflect blood eosinophilia and fractional exhaled nitric oxide concentrations but not pulmonary functions in allergic asthmatic children sensitized to house dust mites.
Sacco O; Sale R; Silvestri M; Serpero L; Sabatini F; Raynal ME; Biraghi M; Rossi GA
Pediatr Allergy Immunol; 2003 Dec; 14(6):475-81. PubMed ID: 14675476
[TBL] [Abstract][Full Text] [Related]
14. Predictors of response to therapy with omalizumab in patients with severe allergic asthma - a real life study.
Kallieri M; Papaioannou AI; Papathanasiou E; Ntontsi P; Papiris S; Loukides S
Postgrad Med; 2017 Aug; 129(6):598-604. PubMed ID: 28427296
[TBL] [Abstract][Full Text] [Related]
15. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking.
Pedersen B; Dahl R; Karlström R; Peterson CG; Venge P
Am J Respir Crit Care Med; 1996 May; 153(5):1519-29. PubMed ID: 8630596
[TBL] [Abstract][Full Text] [Related]
16. Development of a novel enzyme-linked immunosorbent assay for blood and urinary eosinophil-derived neurotoxin: a preliminary study in patients with bronchial asthma.
Morioka J; Kurosawa M; Inamura H; Nakagami R; Mizushima Y; Chihara J; Yokoseki T; Kitamura S; Omura Y; Shibata M
Int Arch Allergy Immunol; 2000 May; 122(1):49-57. PubMed ID: 10859469
[TBL] [Abstract][Full Text] [Related]
17. Fixed airflow obstruction relates to eosinophil activation in asthmatics.
Mogensen I; Alving K; Dahlen SE; James A; Forsberg B; Ono J; Ohta S; Venge P; Borres MP; Izuhara K; Janson C; Malinovschi A
Clin Exp Allergy; 2019 Feb; 49(2):155-162. PubMed ID: 30365193
[TBL] [Abstract][Full Text] [Related]
18. Utility of serum periostin and free IgE levels in evaluating responsiveness to omalizumab in patients with severe asthma.
Tajiri T; Matsumoto H; Gon Y; Ito R; Hashimoto S; Izuhara K; Suzukawa M; Ohta K; Ono J; Ohta S; Ito I; Oguma T; Inoue H; Iwata T; Kanemitsu Y; Nagasaki T; Niimi A; Mishima M
Allergy; 2016 Oct; 71(10):1472-9. PubMed ID: 27113353
[TBL] [Abstract][Full Text] [Related]
19. Eosinophil degranulation is more important than eosinophilia in identifying asthma in chronic cough.
Kim CK; Callaway Z; Kim DW; Kita H
J Asthma; 2011 Dec; 48(10):994-1000. PubMed ID: 22022864
[TBL] [Abstract][Full Text] [Related]
20. Urinary eosinophil-derived neurotoxin/protein X: a simple method for assessing eosinophil degranulation in vivo.
Cottin V; Deviller P; Tardy F; Cordier JF
J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):116-23. PubMed ID: 9449510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
